Depression is the psychiatric condition most frequently identified in people with epilepsy. Nevertheless, it is very often unrecognized and untreated. It should be considered a serious problem because of its significant negative impact on the patient's quality of life and increased potential for self-injury or suicide. An important tool in understanding the variety of depressive syndromes in epilepsy is the timing of the mood symptoms in relation to the ictus:
Preictal symptoms of depression can appear hours to days before a seizure. This phenomenon has been well documented in studies utilizing rating scales for depression and associated symptoms before and after seizures. Patients typically report feelings of irritability, inability to experience any pleasure in activities, problems with concentration, and feelings of hopelessness. The intensity of these symptoms worsens over time. Symptoms usually remit after seizures, though in some patients symptoms may persist into the postictal period.
During the ictal phase, the mood may suddenly change to sadness, suicidal ideation or feeling of helplessness or hopelessness with no environmental precipitant. Symptoms of depression and fear are the two most common ictal expressions of psychiatric symptoms. Often they may be the only symptoms of the ictus, hence presenting as simple partial seizures. More often than not, however, these symptoms last less than 30 seconds and are followed by alteration of consciousness leading to a complex partial or secondarily generalized tonic-clonic seizure. Some investigators have suggested that the presence of psychiatric "auras" may be associated with a higher occurrence of interictal depressive disorders in patients with epilepsy.
Ictal crying (dacrystic seizures) is rare, despite the prevalence of unpleasant or dysphoric mood auras. Ictal laughing (gelastic seizures) is more common, yet the experience of euphoria during an ictus (a "Dostoyevskian seizure") is extremely rare. The divergence may represent an uncoupling of emotional experience from the expression of affect during the ictal phase.
During the postictal phase, symptoms of depression are common but often overlooked. In a recent study, 43% of 100 consecutive patients with intractable partial epilepsy experienced symptoms of depression after more than half of their seizures. The average duration of these symptoms was 24 hours, with a range from several minutes to up to a week. Of these 43 patients, 18 reported clusters of at least five symptoms of depression that lasted at least 24 hours and mimicked the symptoms of a major depressive episode, and 13 experienced suicidal thoughts. Most of the patients who reported symptoms of depression also reported symptoms of anxiety and disturbances in their sleep and appetite. Clearly, these symptoms have a greater impact in the life of patients than the actual seizure.
During the interictal phase, depression is the most frequent comorbid psychiatric disorder. Interictal depressive disorders result from a variety of factors including:
The depressive disorders in people with epilepsy may be identical to those of people in the general population, but in up to 50% of people with epilepsy, interictal depressive episodes present features considered "atypical." Symptoms of irritability, poor frustration tolerance, and mood lability may be more prevalent and obvious than other symptoms typical of "classic" depression, such as inability to find pleasure in activities, problems with sleep and appetite, or feelings of helplessness and hopelessness. Their symptoms tend to last between a few hours and several days and may remit spontaneously for several days before recurring without any apparent reason. This on-off course of symptoms can persist for a very long time, to the point that patients and their families often consider these "mood changes" to be normal and "a part of the epilepsy." Thus, they fail to report them to the physician and the depressive episodes go untreated while having a significant taxing effect on the quality of life of the patients and their families.
Treatment of pre-ictal, ictal, and postictal symptoms of depression depends largely on seizure control. The efficacy of antidepressant drugs in treating postictal depressive episodes has not yet been evaluated.
On the other hand, patients with sustained episodes of interictal depression may benefit from antidepressants. These drugs seldom compromise seizure control in clinical practice.
Adapted from: Holzer JC and Bear DM. Psychiatric considerations in patients with epilepsy. In: Schachter SC, Schomer DL, eds. The comprehensive evaluation and treatment of epilepsy. San Diego, CA: Academic Press; 1997. p. 131-148.
With permission from Elsevier (www.elsevier.com)
Reviewed and extensively revised April 2004 by Andres M. Kanner, M.D., epilepsy.com Editorial Board
In contrast to depressive symptoms, pre-ictal and ictal psychotic symptoms are rare. Ictal psychotic episodes can be the clinical expression of nonconvulsive recurrent seizure activity known as status epilepticus of simple partial, complex partial, or absence seizures. In the case of simple partial status, the diagnosis may often be difficult because scalp recordings may not detect any changes in ictal EEG patterns.
Postictal psychotic symptoms were reported by 7 out of 100 consecutive patients with intractable partial epilepsy in one study. These symptoms were also associated with symptoms of depression, anxiety, and disturbances in sleep and appetite. The duration of these symptoms ranged from 2 to 24 hours.
Psychotic symptoms may cluster and form postictal psychotic episodes, which may occur in 6% to 10% of patients with intractable epilepsy. More often than not, the presence of postictal psychotic episodes is suggestive of more than one seizure focus. Postictal psychotic episodes may last from several hours to several weeks. They usually remit with low doses of antipsychotic medication.
Typically, episodes of postictal psychosis occur in patients who have had epilepsy for at least 10 to 15 years. The episodes tend to follow the occurrence of clusters of generalized tonic-clonic seizures and may appear after a symptom-free lag-time of 12 to 120 hours. Usually, the first symptom is insomnia. If these episodes tend to recur after a cluster of seizures in a particular patient, family members are taught to identify the insomnia and administer antipsychotic medication at low doses, which may abort the psychotic episode. Given the episodic nature of these symptoms and rapid remission after low doses of antipsychotic medication, patients with postictal psychosis should not be prescribed continuous antipsychotic medication.
Recent studies have shown that some patients who experience recurrent postictal psychotic episodes can go on to develop interictal psychotic disorders. In those patients, long-term therapy with antipsychotic drugs may be necessary.
Among the most frequent symptoms of postictal psychosis are:
Interictal psychosis can develop as a schizophrenia-like state or be associated with an affective disorder. The schizophrenia-like psychosis of epilepsy, which is believed to affect between 2% and 8% of patients with long-standing complex partial seizures, has been associated primarily with temporal lobe epilepsy (TLE). Although this type of psychiatric presentation may appear similar to idiopathic schizophrenia, important distinctions can be made. Compared to idiopathic schizophrenia, schizophrenia-like states in epilepsy include:
Psychosis may be the expression of adverse effects of AEDs. The discontinuation of an AED with mood stabilizing properties can also trigger a manic or psychotic depression in patients with an underlying mood disorder that had been controlled with that AED.
Other causes of psychosis include substance use and withdrawal and primary psychiatric conditions such as brief reactive psychosis.
The treatment approach to psychosis in epilepsy depends on the etiology of the symptoms and whether the psychosis is the sustained interictal type. Symptoms limited to the postictal period may remit spontaneously, although antipsychotic medication at low doses is often required. A schizophrenia-like syndrome during the interictal period requires antipsychotic medications.
Adapted from: Holzer JC and Bear DM. Psychiatric considerations in patients with epilepsy. In: Schachter SC, Schomer DL, eds. The comprehensive evaluation and treatment of epilepsy. San Diego, CA: Academic Press; 1997. p. 131-148.
With permission from Elsevier (www.elsevier.com)
Reviewed and extensively revised April 2004 by Andres M. Kanner, M.D., epilepsy.com Editorial Board
A relationship between seizure control and psychotic symptoms in some patients with intractable epilepsies was described in the middle of the 20th century by a Swiss neuropsychiatrist and multiple reports have appeared in the literature since then. The observation that the EEG recordings of these patients normalized during the psychotic episode led some investigators to coin the term "forced normalization" to describe this phenomenon. Some believe that this antagonism between psychosis and epilepsy may explain the therapeutic effect of electroconvulsive therapy (ECT) for psychotic disorders.
This phenomenon, also known as "alternative psychosis," is by no means common. In one study, its prevalence was estimated to be 1% among 697 patients followed at a university epilepsy center.
Forced normalization has been reported in patients with both TLE and generalized epilepsies. A paranoid psychosis (a richness of affective symptoms without clouding of consciousness) has been its most frequent manifestation. It has been observed following the use of various AEDs, including phenytoin (Dilantin, Phenytek), carbamazepine (Tegretol, Carbatrol), ethosuximide (Zarontin), and levetiracetam (Keppra).
Recent observations have suggested that the phenomenon of forced normalization is not restricted to psychotic episodes, but may also present as episodes of major depression.
Adapted from: Holzer JC and Bear DM. Psychiatric considerations in patients with epilepsy. In: Schachter SC, Schomer DL, eds. The comprehensive evaluation and treatment of epilepsy. San Diego, CA: Academic Press; 1997. p. 131-148.
With permission from Elsevier (www.elsevier.com)
Reviewed and extensively revised April 2004 by Andres M. Kanner, M.D., epilepsy.com Editorial Board
Overt aggressive behaviors occur in a minority of people with epilepsy. Certain typical features are common to most episodes of aggression in patients with TLE. These features may differ depending on when they occur:
Ictal phase
Postictal phase
The last feature above is helpful in distinguishing patients with interictal aggression from those with antisocial personality disorders. Aggressive behavior among people with epilepsy may be more common in those whose early life included disruption or physical abuse, or those with histories of fire setting, animal torture, conduct disorder, or substance abuse.
Adapted from: Holzer JC and Bear DM. Psychiatric considerations in patients with epilepsy. In: Schachter SC, Schomer DL, eds. The comprehensive evaluation and treatment of epilepsy. San Diego, CA: Academic Press; 1997. p. 131-148.
With permission from Elsevier (www.elsevier.com)
Reviewed and extensively revised April 2004 by Andres M. Kanner, M.D., epilepsy.com Editorial Board
Anxiety disorders and individual symptoms of anxiety are commonly identified in people with epilepsy. During the ictal phase, panic and fear are the most frequent psychiatric symptoms presenting as an expression of seizure activity. Often ictal fear or panic can be misdiagnosed as a panic disorder, as both types of episodes can produce similar symptoms, such as palpitations, shortness of breath, clammy hands, or pallor or flushing of the face.
To avoid an erroneous diagnosis and treatment, it is essential to distinguish between ictal panic and panic attacks. The following are the principal differences between these two types of events:
| Ictal panic | Panic attack |
| Very short duration (< 30 seconds). | Duration usually several minutes. |
| Intense fear or sensation of doom unlikely. | Intense fear, sensation of "impending doom." |
| Fear usually followed by loss of awareness of surroundings, automatisms; no memory of this period. | Intense sensation of doom may prevent detailed awareness of surroundings. |
| Person not responsive to other people while awareness is lost. | Person remains responsive to other people. |
Patients are also likely to experience symptoms of anxiety during the postictal period. These symptoms include panicky feelings, constant worry, and fear of leaving the house or being left alone. In the study of postictal psychiatric symptoms mentioned above, 45 of 100 consecutive patients with poorly controlled partial epilepsies experienced symptoms of anxiety after more than half of their seizures. The average duration was 24 hours, with a range of several minutes to several days. Postictal symptoms of anxiety occurred together with symptoms of depression and disturbances of sleep and appetite.
Interictal anxiety disorders are relatively frequent and are more prevalent in people with epilepsy than in other people. They can be identical to those identified in people without epilepsy, and include panic disorders, generalized anxiety disorders, and phobias, including agoraphobia and social phobia.
Interictal anxiety disorders result from a variety of factors often acting together. These factors include:
The management of interictal anxiety disorders is similar to the management of idiopathic anxiety. Besides AEDs, the clinician may prescribe anxiolytic and antidepressant medications or behavioral therapy.
Dissociative experiences, in which the patient's sense of identity and memory are disturbed, are another important class of symptoms that may develop during a partial seizure. Dissociative symptoms include depersonalization, derealization, autoscopy (looking at one's body from outside), and multiple personalities. These symptoms tend to be limited to peri-ictal periods.
Adapted from: Holzer JC and Bear DM. Psychiatric considerations in patients with epilepsy. In: Schachter SC, Schomer DL, eds. The comprehensive evaluation and treatment of epilepsy. San Diego, CA: Academic Press; 1997. p. 131-148.
With permission from Elsevier (www.elsevier.com)
Reviewed and extensively revised April 2004 by Andres M. Kanner, M.D., epilepsy.com Editorial Board
|
© 2009 Epilepsy.com. All rights reserved.
Site Map |
Privacy Statement |
Terms of Use |
Problems? Email webmaster@epilepsy.com
|